References
- Khan A, McNally D, Tutschka PJ, Bilgrami S. Paditaxel-induced acute bilateral pneumonitis. Ann. Pharmacother. 1997; 31: 1471–1474.
- Fujimori K, Yokoyama A, Kurita Y, Uno K, Saijo N. Paclitaxel-induced cell-mediated hypersensitivity pneumo-nitis. Oncology 1998; 55: 340–344.
- Goldberg HL, Vannice SB. Pneumonitis related to treat-ment with paclitaxel. J. Clin. Oncol. 1995; 13: 534–535.
- Ramanathan RK, Reddy VV, Holbert JM, Belani CP. Pul-monary infiltrates following administration of paclitaxel. Chest 1996; 110: 289–292.
- Rowinsky EK, Donehower RC. Paditaxel (Taxol). N. Engl. J. Med. 1995; 332: 1004–1014.
- Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, SagaeS. Distant metastases in epithelial ovarian carcinoma. Can-cer 1987; 60: 1561–1566.
- Carty NJ, Foggitt A, Hamilton CR, Royle GT, Taylor I. Pat-terns of clinical metastasis in breast cancer: an analysis of 100 patients. Fur. J. Surg. Oncol. 1995; 21: 607–608.
- Akoun GM, Cadranel JL, Milleron BJ, D'Ortho MPF, Mayaud CM. Bronchoalveolar lavage cell data in 19 pa-tients with drug-associated pneumonitis (except amiodarone). Chest 1991; 99: 98–104.
- Kerr VE, Cadman E. Pulmonary metastases in ovarian cancer. Cancer 1985; 56: 1209–1213.
- Fernandez K, O'Hanlan KA, Rodriguez-Rodriguez L, Ma-rino WD. Respiratory failure due to interstitial lung metastases of ovarian carcinoma reversed by chemotherapy. Chest 1991; 99: 1533–1534.